Memphis Pharmaceuticals & Chemical Industries reported earnings results for the nine months ended March 31, 2024. For the nine months, the company reported sales was EGP 664.58 million compared to EGP 440.47 million a year ago. Net income was EGP 166.37 million compared to EGP 35.06 million a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
85.1 EGP | -1.52% |
|
-2.62% | +35.70% |
1st Jan change | Capi. | |
---|---|---|
+35.70% | 99.72L | |
+62.66% | 84TCr | |
+40.42% | 62TCr | |
-4.37% | 36TCr | |
+17.16% | 33TCr | |
+9.87% | 30TCr | |
+15.66% | 24TCr | |
+17.90% | 23TCr | |
+14.86% | 17TCr | |
+0.45% | 16TCr |
- Stock Market
- Equities
- MPCI Stock
- News Memphis Pharmaceuticals & Chemical Industries
- Memphis Pharmaceuticals & Chemical Industries Reports Earnings Results for the Nine Months Ended March 31, 2024